Article content

Martin Shkreli, who caused public outrage after raising the price of a prescription drug by more than 5,000 per cent, was arrested on Thursday for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund and a pharmaceutical company he previously headed.

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Martin Shkreli, CEO reviled for drug price gouging, arrested on securities fraud charges Back to video

The 32-year-old likes sunglasses, golf shirts, the hip-hop artist Eminem, a bottle of 1982 Lafite-Rothschild, and jacking up the price of a pill used by people who suffer from HIV.





[/np_storybar]

Reuters witnessed Shkreli’s predawn arrest at the Murray Hill Tower Apartments in midtown Manhattan. Law enforcement, including FBI agents, could be seen escorting the hoodie-clad 32-year-old into a car.

Many on social media said Shkreli was getting what he deserved. On Twitter, the top hashtag and keyword related to his arrest was #Karma.

Shkreli, who is now chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, was charged in a federal indictment filed in Brooklyn relating to his management of hedge fund MSMB Capital Management and biopharmaceutical company Retrophin Inc.